Loading chat...
NY A01057
Bill
Status
1/8/2025
Primary Sponsor
Maritza Davila
Click for details
AI Summary
-
Authorizes school districts, BOCES, charter schools, and non-public elementary and secondary schools to maintain FDA-approved opioid reversal agents (such as naloxone) on-site at each instructional facility
-
Allows quantities and types of opioid reversal agents to be determined by the Commissioner of Education in consultation with the Commissioner of Health
-
Permits school employees and contractors to administer opioid reversal agents during emergencies to students or staff experiencing opioid overdose
-
Takes effect 120 days after becoming law, with rulemaking authority granted immediately to prepare for implementation
Legislative Description
Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.
Last Action
referred to education
1/7/2026